mental health

mental health

mental health

What we know about the effectiveness of the antidepressant fluvoxamine versus covid-19

A clinical trial in Brazil evaluated the effectiveness of a depression drug versus placebo in reducing the risk of hospitalisation for SARS-CoV-2 infection. Administration of 100 mg twice daily for ten days to high-risk outpatients with early diagnosis reduces the need for hospitalisation.

1